Work, school, errands, commutes … it makes sense that we are more stressed during the day than when we're sleeping. And we do, in fact, produce more glucocorticoid (GC) – aka the stress hormone – during our waking hours. Now Weizmann scientists have found that GC also helps suppress cancer growth, meaning that perhaps we should be administering cancer drugs at night, while our bodies aren't fighting the cancer themselves.
October 06, 2014
Leukemia cells are able to stay alive, aggressively dividing, virtually forever… but how? New Weizmann research suggests that about 25 percent of the time, there is a ""balance of terror"" between the cancer-promoting gene and a second, normal version. This normal gene functions alongside the mutation, keeping the cells both cancerous and alive.
September 29, 2013
Prof. Yardena Samuels, who comes to Weizmann from the National Human Genome Research Institute, uses DNA sequencing to identify new genetic mutations involved in melanoma. She has already made progress by identifying a mutation – found in nearly one-fifth of melanoma cases – in a gene that is already targeted by an approved drug.
December 01, 2012
In a step toward personalized medicine, a Weizmann-led interdisciplinary team that included mathematicians, pediatricians, oncologists, and others has created a mathematical model that helps explain why some patients develop post-chemo infections.
September 14, 2012
Prof. Ehud Shapiro leads research that shows how leukemia can evade chemotherapy. Using his method of mapping the family trees of cells, the team found that slowly dividing cancer cells are most likely to survive the toxic therapy. This could lead to new ways of fighting cancer.
Scientists from the Weizmann Institute and the University of Perugia have improved on a method of transplanting bone marrow-based stem cells from a mismatched donor.
A team of Weizmann Institute scientists has identified part of the reason why some pediatric cancers can regress spontaneously.
At its 2008 Gala, the New York Region of the American Committee for the Weizmann Institute of Science will honor three families whose involvement with the American Committee spans several generations.
Weizmann scientists have developed a new method for reconstructing a cell's ""family tree,"" and have applied this technique to trace the history of the development of cancer.
